Piper Sandler Downgrades IDEXX Laboratories to Neutral, Announces $525 Price Target

IDEXX Laboratories, Inc. +0.27%

IDEXX Laboratories, Inc.

IDXX

499.72

+0.27%

Piper Sandler analyst David Westenberg downgrades IDEXX Laboratories (NASDAQ: IDXX) from Overweight to Neutral and announces $525 price target.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via